医学资讯BireociclibBRIGHT-2
Bireociclib联合氟维司群治疗内分泌进展后的晚期乳腺癌：BRIGHT-2 III期随机临床试验及比较综合分析
By MedXY|2026年5月27日
本综述整合了BRIGHT-2试验结果和荟萃分析数据，证实Bireociclib联合氟维司群显著改善HR+/HER2-晚期乳腺癌患者的无进展生存期。
MedXY新闻
中文标签BRIGHT-2
向 MedXY AI 提问
最新新闻
标签
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.